CTRI/2024/05/066741尚未招募3 期
Heat stable Carbetocin versus Oxytocin in Active Management of the third stage of Labour to Prevent Postpartum Haemorrhage in women delivering vaginally. - NI
Dr Suraj Ashokrao Mokade0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18 TO 35 years
- •Pregnant patients with gestational age more than or equal to 37 weeks
- •Singleton pregnancy with cephalic presentation
- •Expected to deliver vaginally with cervical dilatation more than or equal to 5 cm
- •Hemoglobin more than 9gm in recent 3rd trimester report
- •Willing to participate in the study
排除标准
- •Previous lower segment caesarean section
- •High risk including antepartum haemorrhage traumatic Postpartum haemorrhage
- •abruption placenta recurrent pregnancy loss multiple pregnancies polyhydramnios
- •perineal or cervical tears during Labour and delivery
- •Medical disorders such as coagulation disorder thrombocytopenia renal disorder hepatic disorder severe cardiac disorder asthma epilepsy
- •Patients with previous uterine surgery
- •Patients requiring blood transfusion before delivery
- •Patient allergy to carbetocin
- •Patients are not willing to sign informed consent
研究者
相似试验
尚未招募
3 期
Comparison of Carbetocin with Oxytocin in preventing postpartum hemorrhage after normal vaginal deliveryCTRI/2023/07/055317ivya Mercy Anil
尚未招募
3 期
Carbetocin vs Oxytocin for prevention of blood loss after normal vaginal deliveryCTRI/2023/06/053901Maharaja Agrasen Medical College, Agroha,Hisar
尚未招募
不适用
A Randomised control trial comparing the efficacy of two drugs namely Carbetocin and Oxytocin in the active management of third stage of labourCTRI/2022/09/045254RAJAGIRI HOSPITA
招募中
4 期
Comparative study of uterotonic agents in the prevention of post partum haemorrhage following vaginal deliveryCTRI/2023/09/057333Ramaiah medical college
尚未招募
2 期
study of Oxytocin versus Carbetocin for the prevention of primary post partum hemorrhage following caesarean delivery in pregnant womeCTRI/2024/04/065815self
